317355
Japan's national metabolic syndrome examination and health guidance mandate – What can we learn from their experience?
Akiko S. Hosler, PhD,
Department of Epidemiology and Biostatistics, University at Albany School of Public Health, Rensselaer, NY
Japan introduced the so-called Metabolic Syndrome Mandate in 2008. Under this legislation, all health care insurers (local administrators of the national health insurance systems) are required to provide annual, systematic health examination to all enrollees and their dependents aged 40 to 74 years. The health examination features laboratory tests and physical examination to evaluate metabolic risk factors including waist circumference, BMI, blood pressure, lipids, blood glucose, and smoking. The Mandate also requires all health care insurers to provide annual health guidance (HG) to individuals who are deemed to require health improvement. Two types of 6-month HG programs are offered: intensive HG (personalized lifestyle modification coaching, for those who with high risks) and enhanced HG (initial counseling and self-lifestyle modification, for those with moderate risks). Adults with low metabolic risks receive informational resources only. The preliminary study of the national electronic medical records found that for 2008-2011, 20.2 to 23.5 million eligible adults participated in the health examination annually (39 to 45% participation rate), and 4.0 to 4.3 million adults became eligible for HG due to elevated metabolic risks. Of those, 309,000 to 643,000 adults completed HG programs (7.7 to 15.5 % completion rate). Although the rates of participation and completion were still low, significant impacts were already seen in both clinical and economic indicators after 12 months from baseline. Overall and for each gender and age sub-groups, those who completed the intensive HG program achieved greater reductions in waist circumference (2.2 to 3.2cm), BMI (0.6 to 0.9 kg/m2), and body weight (1.9 to 2.2 kg), and also had greater improvements in fasting blood glucose (1.7 to 3.1 mg/dl), blood pressure (systolic 2.0 to 3.4 mmHg), and lipids (triglycerides 26.4 to 27.2 mg/dl) compared to thier controls (non-intensieve HG participants) as well as those completed enhanced HG. Furthermore, the intensive HG groups also achieved the largest reduction in health care costs for hypertension, hyperlipidemia, and diabetes in the same time period. This presentation will discuss implications of the Mandate in public health and medical care communities in Japan, and what the U.S. can learn from Japan’s experience.
Learning Areas:
Administer health education strategies, interventions and programs
Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Provision of health care to the public
Public health or related laws, regulations, standards, or guidelines
Public health or related public policy
Learning Objectives:
Describe how Japan used legislation to prevent and control multiple chronic disease risk factors among at-risk adults
Discuss the improvements in clinical indicators and savings in medical expenditures achieved by the legislation
Keyword(s): Chronic Disease Prevention, Health Law
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I am a professor of Epidemiology with research interests in chronic disease prevention and control, and served as the principal investigator for several research projects focusing on diabetes and metabolic disorders in diverse populations. I have also been serving as an external consultant for the Japan Public Health Association and the Japanese Ministry of Health, Labor and Welfare on chronic disease prevention issues in Japan and abroad.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.